Form4insider filings, from the source

SEC Form 4 · accession 0001077183-19-000016

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
George Cardoza
Officer — President, Pharma Services
Period of report
Feb 27, 2019
Accepted (ET)
Feb 28, 2019 · 7:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 27, 2019M30,000$3.45A244,089D
Common Stockholding———20,000ITrust by Self

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$3.45Feb 27, 2019M30,000DMar 5, 2015Mar 5, 2019Common Stock30,0000D
Stock Option (Right to Buy)F3$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock200,000200,000D
Stock Option (Right to Buy)F4$4.78holding———May 4, 2016May 4, 2020Common Stock200,000200,000D
Stock Option (Right to Buy)F5$7.52holding———Apr 28, 2018Apr 28, 2022Common Stock200,000200,000D
Stock Options (Right to Buy)F6$8.03holding———Feb 26, 2019Feb 26, 2023Common Stock192,500192,500D

Explanation of responses